Clinical Trials Browser

Adenocarcinoma, Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Rectal Diseases, Colorectal Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT00050349 2017-03-01

EPO906 in Carcinoid and Other Neuroendocrine Tumors

Phase 2 Completed

33 enrolled

EndocrineNET

Carcinoid Tumor, Carcinoma, Vipoma, Neoplasm Metastasis, Neoplasms, Gastrinoma, Neuroendocrine Tumors

NCT01731925 2017-01-31

SUNLAND

Phase 2 Unknown

44 enrolled

Endocrine

Carcinoid Tumor, Neoplasm Metastasis

NCT02409849 2015-04-07

Octreotide LAR as Maintenance Treatment for Patients With NEC

Phase 2 Unknown

92 enrolled

Endocrine

Neoplasm Metastasis, Carcinoma, Neuroendocrine

NCT01886287 2015-01-12

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Phase 2 Terminated

2 enrolled 4 charts

EndocrineNET

Diarrhea, Flushing, Neoplasm Metastasis, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT00434109 2012-09-14

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

Phase 2 Completed

39 enrolled 11 charts

EndocrineNET

Carcinoid Tumor, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Neuroendocrine Tumors

NCT00466856 2012-05-18

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Phase 2 Terminated

10 enrolled

EndocrineHead & Neck

Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Pheochromocytoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Phase 2 Completed

67 enrolled

EndocrineGastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

Clinical Trials

Pan-MSI-ACSE

METALLICA

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

EVACEL

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

TheraSphere for the Treatment of Liver Metastases

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

A Study of Axitinib in Advanced Carcinoid Tumors

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

EPO906 in Carcinoid and Other Neuroendocrine Tumors

SUNLAND

Octreotide LAR as Maintenance Treatment for Patients With NEC

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases